ARCHIVES

ODAC To Review Taxol Nov. 16; NCI, Bristol to Discuss Pricing

This article is from The Cancer Letter archive.

Vol. 18 No. 41 | October 23, 1992

Download PDF Visit The Full Archive

Related Articles

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

October 20, 2000

Laertrile Clinical Study Provides Solid Evidence: It Is Useless

May 8, 1981

In Brief: AACR To Have Fur Symposia, Including One With ASCO; McConnell Names TRTP Director

March 21, 1986

Competition For Center Grants Higher In FY95, Kimes Tells BSC

November 25, 1994

Cancer Centers Could Form Network for Genetics Research, NCI Says

April 12, 1996

NCI director says rules hurt retention, recruitment, cites Liotta’s departure.

April 8, 2005